In line with this hypothesis, NAFLD-related insulin resistance is correlated positively with PGC-1α promoter methylation, and negatively with PGC-1α gene expression [77]. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.